Astrana Health Reiterates Outlook: Sees 2024 EPS $1.28-$1.52 vs $1.51 Est., Total Revenue $1.65B-$1.85B vs $1.76B Est.
Portfolio Pulse from Benzinga Newsdesk
Astrana Health has reaffirmed its financial outlook for 2024, projecting earnings per share (EPS) in the range of $1.28 to $1.52, compared to the estimated $1.51. The company also forecasts total revenue to be between $1.65 billion and $1.85 billion, versus the estimated $1.76 billion.

May 07, 2024 | 9:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Astrana Health reiterates its 2024 financial outlook, with EPS and revenue projections slightly below or within analyst estimates.
Astrana Health's reaffirmation of its 2024 financial outlook suggests stability and confidence in its business operations and financial planning. The EPS and revenue projections are closely aligned with analyst expectations, indicating no significant surprises or changes in the company's performance trajectory. This could lead to a neutral short-term impact on the stock price, as the market has likely already priced in these expectations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100